?CORE B The Biostatistics Core (Core B) will provide comprehensive, centralized biostatistical support for all four research projects. This support will integrate the biostatistical activities at the University of Texas MD Anderson Cancer Center (MDACC), Harvard University, and Children's National Health System (CNHS) at The George Washington University. These activities will include design of pre-clinical studies and clinical trials, data analysis, and data management. Dr. Peter Thall, PhD, who has collaborated with Drs. Shpall, Rezvani, Bollard, and Molldrem for many years on several different protocols and grants, will serve as Director of the Biostatistics Core. The Core personnel, Dr. Thall and Roland Bassett, MS, are highly experienced biostatisticians in the Department of Biostatistics of the MDACC. Dr. Thall, will coordinate the biostatistical support. Conduct of clinical trials will utilize the Biostatistics Department's Clinical Trial Conduct website.
The specific aims of Core B are to (1) coordinate and manage biostatistical activities and ensure that investigators have ready access to biostatistical consultation, including experimental design, statistical modeling, data analysis, scientific interpretation, and reporting, (2) provide statistical design, modeling, and data analysis for pre-clinical studies, (3) provide statistical design and infrastructure for conduct of clinical trials, including sequentially adaptive futility/safety monitoring and dose-finding, and (4) provide support for data management in collaboration with the Administrative Core. If needed, the Core will draw on other resources and personnel in the Biostatistics Department at MDACC.

Public Health Relevance

-CORE B Implementation of established statistical methods for study design and data analysis, or development of novel methods as needed, are essential to ensure the scientific validity of the research projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA148600-08
Application #
9788279
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
8
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Agha, Nadia H; Baker, Forrest L; Kunz, Hawley E et al. (2018) Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the ?2-adrenergic receptor. Brain Behav Immun 68:66-75
Yang, Tian-Hui; St John, Lisa S; Garber, Haven R et al. (2018) Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol 201:1389-1399
Barrett, A John; Prockop, Susan; Bollard, Catherine M (2018) Virus-Specific T Cells: Broadening Applicability. Biol Blood Marrow Transplant 24:13-18
Trujillo-Ocampo, Abel; Cho, Hyun-Woo; Herrmann, Amanda C et al. (2018) Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease. Cytotherapy 20:1089-1101
Simpson, Richard J; Bigley, Austin B; Agha, Nadia et al. (2017) Mobilizing Immune Cells With Exercise for Cancer Immunotherapy. Exerc Sport Sci Rev 45:163-172
Kerros, Celine; Tripathi, Satyendra C; Zha, Dongxing et al. (2017) Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells. J Biol Chem 292:10295-10305
Cruz, Conrad R Y; Bollard, Catherine M (2017) Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells. Curr Drug Targets 18:271-280
Robinson, Simon N; Thomas, Michael W; Simmons, Paul J et al. (2017) Non-fucosylated CB CD34+ cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation. Cytotherapy 19:285-292
Houghtelin, Amy; Bollard, Catherine M (2017) Virus-Specific T Cells for the Immunocompromised Patient. Front Immunol 8:1272
Peters, Haley L; Tripathi, Satyendra C; Kerros, Celine et al. (2017) Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunol Res 5:319-329

Showing the most recent 10 out of 102 publications